InvestorsHub Logo
Followers 2
Posts 2974
Boards Moderated 0
Alias Born 06/23/2017

Re: FDApproved post# 43306

Wednesday, 03/23/2022 9:38:14 AM

Wednesday, March 23, 2022 9:38:14 AM

Post# of 44784
Wow another incredible result for sure. The statistically irrelevant mortality rate is their pride and joy. Reminds me of the 100% success rate in ARS. But this one was nowhere near 100%. So what does that mean? The market is loving’ it though. And based on how lighting fast this trial was, they should be able to get their phase 2/3 done in about a decade. But will this just go into oblivion with the rest of them, only to rear their ugly heads in the company’s presentations?

Did you also see the part where they were name dropping the NIH and the DOD? Only been 5 years since we heard about them. And can’t forget about the beloved ARS. It gets a full mention in this release. Those preclinical studies done many years ago are just as valid today as they were back then you know. And just because they haven’t had anyone knock on their door about it for many years, doesn’t mean it can’t be used to…pump up the jam.

The clown show strikes again. LMAO x 800k at way way way too much!!!